Skip to main content

Animations

MJFF Publications

2101 - 2110 of 8620 Results
Title
Year
  • Year
  • 2016
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2016
  • 2016
  • 2018
  • 2017
  • Summary Details
    OPEN
    Title: Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/aww180
    Citation Count: 77
  • Summary Details
    OPEN
    Title: Effects of Baseline CSF α-Synuclein on Regional Brain Atrophy Rates in Healthy Elders, Mild Cognitive Impairment and Alzheimer’s Disease
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc0
    DOI - Digital Object Identifier: 10.1371/journal.pone.0085443
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Clinical Comparison of 99mTc Exametazime and 123I Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain Injury
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0087009
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson’s Disease Patients
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0142582
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Predictive Big Data Analytics: A Study of Parkinson’s Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0157077
    Citation Count: 138
  • Summary Details
    OPEN
    Title: Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc0
    DOI - Digital Object Identifier: 10.1371/journal.pone.0175674
    Citation Count: 132
  • Summary Details
    OPEN
    Title: Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s Disease
    Journal Name: Aging and disease
    Publisher: Aging and Disease
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.14336/ad.2015.1110
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Age at onset and Parkinson disease phenotype
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000002461
    Citation Count: 321
  • Summary Details
    OPEN
    Title: Longitudinal analysis of impulse control disorders in Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000005816
    Citation Count: 222
  • Summary Details
    OPEN
    Title: Latent Cognitive Phenotypes in De Novo Parkinson’s Disease: A Person-Centered Approach
    Journal Name: Journal of the International Neuropsychological Society
    Publisher: Cambridge University Press (CUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1017/s1355617717000406
    Citation Count: 9
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.